<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04734041</url>
  </required_header>
  <id_info>
    <org_study_id>DH10320</org_study_id>
    <nct_id>NCT04734041</nct_id>
  </id_info>
  <brief_title>Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)</brief_title>
  <official_title>Integrative Medicine for Hypermobility Spectrum Disorder (HSD) and Ehlers-Danlos (EDS) Syndromes: A Mixed-methods Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University of Natural Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Healthy Living Community</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University of Natural Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A feasibility study of an integrative medicine program among patients with Hypermobility&#xD;
      Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall purpose of this study is to assess the feasibility of conducting a 9-week&#xD;
      integrative medicine program that is comprised of a prescribed anti-inflammatory&#xD;
      (Mediterranean) diet, as well as general behavioral and psychosocial support among patients&#xD;
      with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS), in order to&#xD;
      determine the recruitment potential in this population and to measure the ability of&#xD;
      individuals to complete the program. Participants will be prescribed a food plan, and&#xD;
      adherence to and feasibility of the food plan will be measured through participant food&#xD;
      tracking and a subjective assessment of the food plan in a brief satisfaction survey.&#xD;
&#xD;
      This study aims to recruit 20 patients with HSD or EDS and make preliminary observations&#xD;
      regarding the effects of integrative medical care on pain reduction and improved quality of&#xD;
      life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 23, 2020</start_date>
  <completion_date type="Actual">July 2, 2021</completion_date>
  <primary_completion_date type="Actual">July 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Feasibility study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>9 weeks</time_frame>
    <description>Number of participants enrolled per month, over the 4 month open recruitment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention rate</measure>
    <time_frame>9 weeks</time_frame>
    <description>Proportion of participants completing the mid-study or end-of-study visits</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to the dietary recommendations</measure>
    <time_frame>5, 9 weeks</time_frame>
    <description>Estimated daily dietary intake recorded in a food tracker app</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to food tracking</measure>
    <time_frame>5, 9 weeks</time_frame>
    <description>Reporting per week of dietary intake recorded in a food tracker app</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Visual Analog Scale for Pain (VAS)</measure>
    <time_frame>Baseline, 5 weeks, 9 weeks</time_frame>
    <description>Baseline, 5-week, and 9-week pain scale scores on a 10-point scale. The numeric measurement of pain between 0 &quot;no pain&quot; and 10 representing &quot;worst pain&quot; will be used.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient-Reported Outcomes Measurement Information System (PROMIS-29)</measure>
    <time_frame>Baseline, 5 weeks, 9 weeks</time_frame>
    <description>Baseline, 5-week, and 9-week PROMIS pain intensity on a scale of 0 to 10. Higher scores represent greater intensity of pain.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Assessment of Chronic Illness Care (PACIC+)</measure>
    <time_frame>Baseline, 5 weeks, 9 weeks</time_frame>
    <description>Baseline, 5-week, and 9-week assessment. The PACIC+ consists of 26 items with Likert scale responses on a 5 point scale from &quot;Almost never&quot; to &quot;Almost always,&quot; with higher scores representing greater satisfaction with care. The PACIC provides summary scores for attitudes regarding patient-centered care, living with chronic illness, and chronic illness care. All subscales are averages of selected items that range between 1 (poor quality of care received) and 5 (excellent quality of care received).</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Ehlers-Danlos Syndrome</condition>
  <condition>Hypermobile EDS (hEDS)</condition>
  <condition>Hypermobility Syndrome</condition>
  <condition>EDS</condition>
  <arm_group>
    <arm_group_label>Integrative Medicine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Anti-inflammatory (Mediterranean) diet, as well as general behavioral and psychosocial support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Anti-inflammatory (Mediterranean-style) diet</intervention_name>
    <description>Prescription of an anti-inflammatory diet, which encourages increasing whole fruits, vegetables, and grains, as well as balancing macronutrients (proteins, carbohydrates, and fat) for every meal.</description>
    <arm_group_label>Integrative Medicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral and psychosocial support</intervention_name>
    <description>Capture a complete and detailed medical history and background. Discuss familial and social support, provide psychosocial support, assess the patient's current self-management strategies for self-care, and assess the patient's current self-management strategies for mental health. Recommendations will be made in accordance with the needs of the participant.</description>
    <arm_group_label>Integrative Medicine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-65&#xD;
&#xD;
          -  Beighton score of 4 or more to confirm joint hypermobility diagnosis&#xD;
&#xD;
          -  Baseline VAS Score of 1 or more&#xD;
&#xD;
          -  Not currently, or already a patient of Dr. Schaefer and Healthy Living Community&#xD;
&#xD;
          -  Ability to provide written informed consent&#xD;
&#xD;
          -  Willingness to participate in 9-week integrative medicine intervention (and make&#xD;
             dietary and lifestyle changes)&#xD;
&#xD;
          -  Willingness to attend 1 in-person screening visit and 2 virtual office visits (or 3&#xD;
             virtual visits, if medical documentation of Beighton score can be provided in advance&#xD;
             of enrollment, and all other criteria are met)&#xD;
&#xD;
          -  Access to an electronic device for MyFitnessPal food-tracker use (i.e mobile device,&#xD;
             tablet, laptop)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant and lactating women, or planned pregnancy over the next 3 months&#xD;
&#xD;
          -  Consumption of more than 14 (men) or 7 (women) alcoholic drinks per week&#xD;
&#xD;
          -  History of disordered eating or eating disorder&#xD;
&#xD;
          -  Body mass index (BMI) considered underweight (&lt;18.5)&#xD;
&#xD;
          -  Weight loss from metastatic cancer&#xD;
&#xD;
          -  Unable to make dietary changes or participate in a 9-integrative medicine nutritional&#xD;
             intervention&#xD;
&#xD;
          -  Those with significant dietary changes, new medications, or new exercise routines&#xD;
             within the past 90 days&#xD;
&#xD;
          -  Currently, or already, a patient of Dr. Schaefer and Healthy Living Community&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rich Barrett, ND</last_name>
    <role>Study Chair</role>
    <affiliation>NUNM Institutional Review Board Chair</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National University of Natural Medicine</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Healthy Living Community</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 22, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 2, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University of Natural Medicine</investigator_affiliation>
    <investigator_full_name>Douglas Hanes</investigator_full_name>
    <investigator_title>Associate Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ehlers-Danlos Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 3, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04734041/Prot_SAP_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 5, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04734041/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

